ViVitro labs introduces “Set it and forget it” heart valve durability tester
by CM Staff
A multidisciplinary team of mechanical, electronic, and software engineers spent more than 3 years in R&D developing the device.
The ViVitro Labs Heart Valve Durability Tester with ADC™ technology launches at TCT 2022 in booth 542 on September 17-19, 2022, at the Boston Convention and Exhibition Center. (CNW Group/ViVitro Labs Inc.)
VICTORIA — ViVitro Labs has launched the ViVitro Labs Heart Valve Durability Tester with ADC™ technology at TCT 2022 in booth 542 to be hosted from September 17 to the 19th at the Boston Convention and Exhibition Center.
Heart Valve Durability Testers measure the longevity and performance of artificial heart valve prostheses in accelerated conditions to ensure devices are safe before being used in patients.
A multidisciplinary team of mechanical, electronic, and software engineers spent more than 3 years in R&D developing the device, drawing upon research in the field of cardiovascular device testing.
The team incorporated feedback from the industry’s cardiovascular device companies including Medtronic, Edwards, Abbott and Boston Scientific as well as start-ups, universities, testing labs, and consultants throughout the process.
“I like the idea of having this chamber we could modify or put different things into,” said Karim Mouneimne, president of ViVitro Labs Inc. and General Manager of Vivitro Labs SASU in a statement.
“This technology helps avoid over pressurizing and over opening valve samples during testing thus improving reliability and reducing costly false negative results.”
